Jones, W.D.; Michener, C.M.; Biscotti, C.; Braicu, I.; Sehouli, J.; Ganapathi, M.K.; Ganapathi, R.N.
RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers. Cancers 2020, 12, 620.
https://doi.org/10.3390/cancers12030620
AMA Style
Jones WD, Michener CM, Biscotti C, Braicu I, Sehouli J, Ganapathi MK, Ganapathi RN.
RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers. Cancers. 2020; 12(3):620.
https://doi.org/10.3390/cancers12030620
Chicago/Turabian Style
Jones, Wendell D., Chad M. Michener, Charles Biscotti, Iona Braicu, Jalid Sehouli, Mahrukh K. Ganapathi, and Ram N. Ganapathi.
2020. "RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers" Cancers 12, no. 3: 620.
https://doi.org/10.3390/cancers12030620
APA Style
Jones, W. D., Michener, C. M., Biscotti, C., Braicu, I., Sehouli, J., Ganapathi, M. K., & Ganapathi, R. N.
(2020). RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers. Cancers, 12(3), 620.
https://doi.org/10.3390/cancers12030620